Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1306343
Reference Type
Journal Article
Title
A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles
Author(s)
Cooper, AJ; Sandhu, S; Losztyn, S; Cernovsky, Z
Year
1992
Is Peer Reviewed?
Yes
Journal
Canadian Journal of Psychiatry
ISSN:
0706-7437
EISSN:
1497-0015
Volume
37
Issue
10
Page Numbers
687-693
Language
English
PMID
1473073
Abstract
Seven of ten pedophiles in hospital completed a double-blind, placebo-controlled two-dose comparison of medroxyprogesterone acetate and cyproterone acetate. Sequential measures during the 28 week study were: patient self-reports, nurses' observations, phallometry, hormone levels and side-effects. The drugs, which performed equivalently, reduced sexual thoughts and fantasies, the frequency of early morning erections on awakening, the frequency and pleasure of masturbation, and level of sexual frustration. Penile responses were also reduced but to a lesser degree and were more variable. Serum testosterone FSH and LH all declined during drug administration, but by the end of the final placebo phase had essentially returned to (or exceeded) pre-drug values. Our experience suggests that only a minority of pedophiles are likely to accept libido-reducing drugs.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity